DEUTERIUM DEPLETED WATER (DDW) USING AS ADJUVANT IN CANCER THERAPY FOR CYTOSTATICS TOXICITY REDUCTION

摘要

The hereby invention addresses to a new application of Deuterium Depleted Water (DDW), namely, its administering, on a concentration of 60 ppm, as daily diet, to adult healthy outbred Wistar rats produces a distinguished lowering of toxic effects produced by cytostatics (Cyclophosphamide, 5-Flourouracil, Farmarubicine and Vinblastine) when they used in these animals mono-chemotherapy. Also, the 60 ppm DDW administering under similar conditions generates a significant cytostatics toxicity (Cyclophosphamide, 5-Flourouracil, Farmarubicine and Vinblastine) used in polychimiotherapy on pet dogs having different types of cancer. These relevant findings confirm the idea of 60 ppm DDW as a new and efficient adjuvant in cancer chemotherapy on pets and humans.